Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Published September 10, 2025 · Recall initiated: July 9, 2025
Summary
FDA records drug Class II recall D-0609-2025, published September 10, 2025 and initiated July 9, 2025. Recalling firm: Boothwyn Pharmacy LLC; Status: Ongoing; Reported quantity: 648 vials; Lot: 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boothwyn Pharmacy LLC
- Distributor
- U.S. Nationwide
- Lot
- 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASemaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn PharmacySeptember 10, 2025
- FDAFluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496September 10, 2025
- FDASemaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn PharmacySeptember 10, 2025
- FDADermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E (Chloroxylenol 0.2%), packaged in a) 800 ml (27September 10, 2025
- FDADermaSarra, External Analgesic, (Camphor 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777September 10, 2025
- FDAKleenFoam, Antimicrobial Foam Soap with Aloe Vera, (Chloroxylenol 0.5%) 34 FL OZ (1000 mL) per cartridge,September 10, 2025
Questions about this recall
Was Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy recalled?
Yes. FDA published recall D-0609-2025 on September 10, 2025. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit